Aflac Inc.
AFL
Market Cap$54.91B
Close$
Earnings Call Q1 2025
May 1, 2025 - AI Summary
Earnings Performance: Aflac Incorporated reported net earnings per diluted share of $0.05 for Q1 2025, significantly impacted by net investment losses compared to net investment gains in Q1 2024. Adjusted earnings per diluted share remained flat at $1.66, indicating stable underlying performance amidst investment volatility.
Sales Growth: Aflac Japan saw a 12.6% year-over-year sales increase, driven by strong sales of the Tsumitasu cancer insurance product, which successfully attracted younger customers. Aflac U.S. also posted a 3.5% year-over-year sales increase, particularly in group life and disability sectors, highlighting positive momentum in both international and domestic markets.
Persistent Growth Strategy: The company is focusing on maintaining strong premium persistency, which remained favorable in both Japan (93.8%) and the U.S. (79.3%). This is crucial as it offsets challenges from reinsurance and policies reaching paid-up status, positioning Aflac for continued growth.
Exclusive for Stockcircle Pro members
Sign up
$100.23
1.2% downside
Current Fair Value
1.2% downsideOvervalued by 1.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $54.91 Billion |
|---|---|
| Enterprise Value | $58.25 Billion |
| Dividend Yield | $2.32 (2.12661218863838%) |
| Earnings per Share | $9.76 |
| Beta | 0.81 |
| Outstanding Shares | 544,707,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 15.4 |
|---|---|
| PEG | -15.64 |
| Price to Sales | 3.27 |
| Price to Book Ratio | 2.11 |
| Enterprise Value to Revenue | 3.43 |
| Enterprise Value to EBIT | 13.27 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Aflac Inc.
CEO: Daniel Amos